Four case reports presenting new acquisitions on the association between breast and endometrial carcinoma
- 1 June 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 37 (3) , 378-380
- https://doi.org/10.1016/0090-8258(90)90371-q
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERSThe Lancet, 1989
- PELVIC IRRADIATION AND TAMOXIFEN AS RISK FACTORS FOR CARCINOMA OF CORPUS UTERIThe Lancet, 1988
- TAMOXIFEN AS RISK FACTOR FOR CARCINOMA OF CORPUS UTERIThe Lancet, 1988
- CONTRASTING ACTIONS OF TAMOXIFEN ON ENDOMETRIAL AND BREAST-TUMOR GROWTH IN THE ATHYMIC MOUSE1988
- Endocrine Effects of Tamoxifen in Postmenopausal Breast Cancer PatientsTumori Journal, 1984
- Estrogen-Like Action of Tamoxifen on Vaginal Epithelium in Breast Cancer PatientsOncology, 1981
- CANCER OF THE UTERINE CORPUS AFTER HORMONAL TREATMENT FOR BREAST CANCERThe Lancet, 1976
- Association of carcinomas of the breast and corpus uteriCancer, 1969
- A comparison of single and multiple primary cancersCancer, 1966